FIELD: pharmaceutics.
SUBSTANCE: group of inventions refers to pharmaceutics and concerns a medical agent containing a combination of N-acetyl-L-cysteine, selenium in the form of selenomethionine and melatonin. Described product can be used for treating carcinoma, dermatological diseases, chronic obstructive pulmonary disease (COPD), amyloidosis, endometriosis and bacterial infections caused by E.coli., for cosmetic treatment of skin, as well as an antibacterial agent with medical device adapted for use in contact with body fluids.
EFFECT: group of inventions provides a synergetic effect at preservation of N-acetyl-L-cysteine, favorable effect on treating COPD, endometriosis, amyloidosis, dermatological diseases and skin states, such as vitiligo, psoriasis, alopecia, seborrheic dermatitis, as well as improved oral absorption.
12 cl, 9 dwg, 1 tbl, 5 ex
